Mometasone Rowex (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasone Rowex, is a corticosteroid presented as a nasal spray for nasal administration. It reduces inflammation in the nasal passages and is indicated for the treatment of allergic rhinitis, including seasonal allergic rhinitis, in adults and children who need symptom control.

GNH USA supplies Mometasone Rowex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution.

Mometasone Rowex, a nasal corticosteroid, acts on the inflammatory pathway of the nasal mucosa to relieve allergic symptoms.

- Allergic rhinitis: reduces nasal congestion, itching, sneezing and rhinorrhea. - Seasonal allergic rhinitis: controls symptoms triggered by pollen or other seasonal allergens.

Mometasone Rowex may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Headache. - Epistaxis (nosebleed). - Throat irritation or dryness. - Altered taste or unpleasant taste. - Cough.

Serious or Rare Side Effects: - Nasal septal perforation. - Severe allergic reaction (anaphylaxis). - Vision changes or cataract formation. - Adrenal suppression with prolonged use. - Opportunistic fungal infection of the nasal passages. - Persistent hoarseness or voice changes.

Before using Mometasone Rowex, consider the following safety measures.

- Pregnancy: consult a healthcare provider before initiating therapy. - Breastfeeding: discuss potential risks with a physician. - Use in children: follow pediatric dosing recommendations and monitor growth. - Nasal surgery or trauma: postpone treatment until healing is complete. - Duration of use: avoid prolonged therapy without medical supervision to limit systemic exposure. - Store at room temperature: keep in the original container, protect from moisture and heat.

Mometasone Rowex can interact with other medicines; review the following categories.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase systemic corticosteroid exposure. - Systemic corticosteroids: additive immunosuppressive effects.

Moderate Interactions (Monitor Closely): - Azole antifungals (e.g., ketoconazole): may raise mometasone levels. - Protease inhibitors such as ritonavir: potential increase in exposure. - Live vaccines: reduced efficacy, consider timing of administration.